INVO BIOSCIENCE OBTAINS REGULATORY APPROVAL TO IMPORT INVOCELL INTO MEXICO
SARASOTA, Fla., March 1, 2021 /PRNewswire/ — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focuse
March 9, 2021
SARASOTA, Fla., March 1, 2021 /PRNewswire/ — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focuse
Interested in exploring a partnership with INVO? Please use the contact form by clicking the button or, click here to download our Media Kit.
Contact Us